Novel coronavirus may enter brain via nose: Study

BERLIN: The novel coronavirus may enter the brain of people through the nose, according to a study published on Monday (November 30) that may help explain some of the neurological symptoms observed in COVID-19 patients, and inform diagnosis and measures to prevent infection. The research, published in the journal Nature Neuroscience, noted that SARS-CoV-2 not … Read more

US COVID-19 vaccine trial in coming weeks after second delay: Novavax

New York: Vaccine maker Novavax Inc said on Monday it has pushed back the start of a US-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November. It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled … Read more

Moderna asks US, European regulators, to allow emergency use of COVID-19 vaccine

New York: Moderna Inc on Monday (November 30) said that it would ask the United States and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must succeed … Read more

COVID-19 vaccines: When and how will it become available; explained

NEW YORK: Pfizer Inc with partner BioNTech SE and Moderna Inc has released trial data showing their COVID-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90% effective. If regulators approve any of the vaccines in coming weeks, the companies have … Read more

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Report

AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, its chief executive Pascal Soriot was quoted as saying on Thursday after questions over the results from its late-stage study. Instead of adding the trial arm to an ongoing U.S. process, a new study would be run to … Read more

President Xi Jinping says China ready to boost global COVID-19 vaccine cooperation

BEIJING: President Xi Jinping said on Saturday that China is ready to step up global COVID-19 vaccine cooperation, and called for better international coordination on policies to facilitate the movement of people. Pharmaceutical companies and research centres around the world are working on potential COVID-19 vaccines, with large global trials of several of the candidates … Read more

G20 leaders asked to provide funds for COVID-19 vaccines, drugs, tests

Geneva: G20 leaders must help close a funding gap to buy vaccines, drugs, and tests to combat the COVID-19 pandemic, a letter from South Africa`s president, Norway`s prime minister, and the heads of the World Health Organization and European Commission said. The letter, seen by Reuters, was sent ahead of the Group of 20`s virtual … Read more

Donald Trump's vaccine team will not brief Joe Biden administration: US senator

WASHINGTON: Officials from Donald Trump’s COVID-19 vaccine distribution effort have not briefed anyone on President-elect Joe Biden`s transition team, and have no plans to do so, a Democratic US senator said after a White House call Thursday. “Just off a conference call with Trump Administration vaccine distribution team,” Senator Chris Murphy said on Twitter. “They confirmed … Read more

Moderna says its vaccine is 94.5% effective in preventing COVID-19

Moderna Inc`s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer Inc`s vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, … Read more

Good news! After Pfizer, now this company gets closer to announce results of COVID-19 vaccine

Amid rising coronavirus COVID-19 cases across the world, US-based biotechnology firm Moderna is getting closer to release  data on its late-stage trials of the coronavirus vaccine candidate. Moderna has announced that it has collected enough data for an interim analysis of the late-stage trial of its coronavirus vaccine, adding that the analysis of the data … Read more